Boothbay Fund Management, LLC Abiomed Inc Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $330,028 - $410,287	1,361 New	1,361 $334,000
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $339,110 - $418,882	-1,128 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $84,681 - $102,702	273 Added 31.93%	1,128 $367,000
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $224,617 - $300,250	855 New	855 $267,000
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $178,683 - $202,877	-712 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $196,789 - $257,922	712 New	712 $203,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.